Pfizer (PFE)

$28.05 0.35 (1.26%)

16:10 EDT PFE Stock Quote Delayed 30 Minutes

Million-Dollar Bets: 7 Stocks to Buy Before They Blast Off

By Yiannis Zourmpanos, InvestorPlace Contributor Feb 2, 2024

In the stock market, identifying promising investment opportunities is a pursuit that demands attention to detail and solid foresight.

Pfizer’s 2024 Comeback: A Dividend Gem in the Pharma Market

Listen to Wall Street and Buy These 3 Stocks Now

3 Standout Stocks That Crushed Q4 Earnings Estimates

Volume:

Previous Close -

Market Cap 157.27B

PE Ratio -561.00

EPS -0.05

Volume (Avg. Vol.) 17.25M

Day's Range $27.67 - $28.09

52-Week Range $25.20 - $37.80

Dividend & Yield $1.64 (5.85%)

PFE Stock Predictions, Articles, and Pfizer News

7 High-Yield Dividend Stocks With High-Upside Potential

By Josh Enomoto, InvestorPlace Contributor Jan 29, 2024

High-yield dividend stocks with potential for upside gains is essentially the Tony Robbins of market opportunities. Robbins gives you a big smile, a warm hug…

3 Dividend Stocks to Buy and Hold for Long-Term Income in 2024

By Charles Munyi, InvestorPlace Contributor Jan 26, 2024

The critical nature of services provided by these dividend stocks for long-term income support generation of predictable cashflows.

3 Healthcare Stocks at 52-Week Lows: Buy or Bye?

By Alex Sirois, InvestorPlace Contributor Jan 26, 2024

Investors should consider picking up these healthcare stocks at 52-week lows to benefit from their potential rebound.

3 Stocks to Sell Before Their Earnings Reports Disappoint in 2024

By Joel Baglole, InvestorPlace Contributor Jan 25, 2024

Here are three stocks to sell before earnings numbers are released during this challenging earnings season.

The Cutting Edge: 3 Stocks to Buy for the Next Generation of Biotech Breakthroughs

By Stavros Tousios, InvestorPlace Contributor Jan 25, 2024

Next gen biotech stocks such as Pfizer, Exscientia, and GSK leverage AI to drive biotech breakthroughs, shaping the future of the industry.

7 Over-Hyped Stocks to Sell Before They Plunge

By Louis Navellier and the InvestorPlace Research Staff Jan 25, 2024

Maybe you’ve fallen for the hype and it's time to think about which stocks to sell. It’s easy to get excited about a stock with…

Maximizing Tax Deductions: 3 Charity-Friendly Stocks to Consider

By Faizan Farooque, InvestorPlace Contributor Jan 23, 2024

Pick charity-friendly stocks for a balanced approach to ethical investing. It's a perfect mix of financial wisdom and social responsibility.

3 Pharma Stocks Could Be the Pills Your Portfolio Needs

By Chris Markoch, InvestorPlace Contributor Jan 18, 2024

These large-cap pharma stocks offer growth and value with existing medicines, deep pipelines and reasonable valuations.

Why Pfizer Stock Is a Fantastic Pharma Comeback Candidate

By David Moadel, InvestorPlace Contributor Jan 17, 2024

If Pfizer can seize a piece of the obesity-drug pie, PFE stock has the potential to rebound sharply this year.

Hidden High-Yielders: 7 Overlooked Stocks with Attractive Dividends

By Chris Markoch, InvestorPlace Contributor Jan 14, 2024

Here are seven overlooked high-yield dividend stocks for you to consider no matter where interest rates at the end of 2024.

Dividend Dynasty: 7 High-Yield Stocks for Long-Term Wealth Accumulation

By Yiannis Zourmpanos, InvestorPlace Contributor Jan 11, 2024

For inventors looking for a financial compass to navigate the sea of investments, here is the realm of the "Dividend Dynasty."

Pfizer’s 2024 Outlook: Is PFE Stock Poised for a Major Rebound?

By Chris MacDonald, InvestorPlace Contributor Jan 11, 2024

Pfizer is certainly a company that will need to continue to battle headwinds moving forward, but is PFE stock worth a buy?

Your Path to Wealth: 3 Stocks Predicted to Double Your Investment by 2025

By Yiannis Zourmpanos, InvestorPlace Contributor Jan 9, 2024

Unveil three standout companies set to double investments by 2025 with groundbreaking strategies in tech and healthcare.

2024’s Top 7 Rebound Picks: Contrarian Stocks in Rising Sectors

By Alex Sirois, InvestorPlace Contributor Jan 8, 2024

These contrarian stocks have all the potential in the world to rise in early 2024, especially after several were held lower last year.

2024’s Market Movers: Top 10 Stocks Set to Dominate the New Year

By Chris Markoch, InvestorPlace Contributor Jan 6, 2024

In a year that's starting with more questions than answers, these 10 names are among the top stocks for 2024

The 3 Best Blue-Chip Stocks to Buy Now

By Faisal Humayun, InvestorPlace Contributor Jan 3, 2024

These are the best blue-chip stocks to buy at attractive levels for high total returns as they represent companies with robust cash flows.

7 Most Undervalued Stocks to Buy Now

By Joel Baglole, InvestorPlace Contributor Jan 3, 2024

Some of the best undervalued stocks to buy are leading companies that are ready to stage big comebacks in 2023 and beyond.

Top Performers: 7 High-Efficiency Stocks With Stellar Profit Per Employee Ratios

By Josh Enomoto, InvestorPlace Contributor Dec 27, 2023

Inundated with myriad ways of assessing publicly traded companies, one unique metric could intrigue investors seeking opportunities in 2024 and that would be high-efficiency stocks.…

Healthcare Heroes: 3 Stocks Innovating in Medicine and Wellness

By Muslim Farooque, InvestorPlace Contributor Dec 27, 2023

Discover these innovative healthcare stocks, backed by the U.S.'s $4.3 trillion health investment, offering stability and high returns.

The Next Bull Run: 3 Stocks Poised for Unprecedented Growth in 2024

By Yiannis Zourmpanos, InvestorPlace Contributor Dec 27, 2023

Are you looking for the next bull run in the stock market? Here are three stocks poised for unprecedented growth in 2024.

Pfizer (PFE)

Million-Dollar Bets: 7 Stocks to Buy Before They Blast Off

Pfizer’s 2024 Comeback: A Dividend Gem in the Pharma Market

Listen to Wall Street and Buy These 3 Stocks Now

3 Standout Stocks That Crushed Q4 Earnings Estimates

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Pfizer (PFE)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

PFE Stock Predictions, Articles, and Pfizer News

Subscriber Sign in